Metrics as of 10/14/2026, 04:46 PM (Berlin time), refresh in progress.
AngioDynamics Stock
AngioDynamics, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- James C. Clemmer
- Employees
- 632
- Market cap
- $473 M
- IPO
- 01/06/2004
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support…
AngioDynamics stock: price history
1D
-2.9%
1W
-2.4%
1M
-27.3%
6M
+3.5%
YTD
-12.5%
1Y
-4.1%
2Y
+80.7%
5Y
-58.9%
10Y
-33.6%
Next earnings date
Next earnings date
06/01/2027 (in 81 days)
Volatility around earnings
~170% stronger price swings than usual
AngioDynamics stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
AngioDynamics, Inc. develops and distributes a broad portfolio of medical instruments for surgical and diagnostic treatment. The portfolio includes specialized products such as the NanoKnife ablation system for tissue removal as well as a range of vascular access solutions, including catheters (such as BioFlo PICC or Midline) and guidewires. The products are used in specialty areas such as oncology, cardiology, and urology. Distribution occurs through both a direct sales team and distributors to medical professionals and facilities worldwide, with a focus on the US market.
- Revenue model
- Hardware sales
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about AngioDynamics
Analyst assessment of AngioDynamics
PRICE TARGET LOW
US$18.00
CONSENSUS
US$19.00
MEDIAN
US$19.00
PRICE TARGET HIGH
US$20.00
0
STRONG BUY
5
BUY
6
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Hold
As of: 13/10/2026
AngioDynamics stock metrics
P/E
-14.23
P/B
2.88
EV/EBITDA
-45.53
RETURN ON EQUITY
-4.3%
NET MARGIN
-8.8%
DEBT/EQUITY
0.07
DIVIDEND YIELD
0.0%
AS OF
31/08/2026
Free float & liquidity
FREE FLOAT
88.4%
FLOAT SHARES
36,538,378
AVG. DAILY VOLUME (30D)
832,012
Insider transactions (SEC)
Nighan Warren JR
Trowbridge Stephen A
Trowbridge Stephen A
Campbell Chad Thomas
Nighan Warren JR
Institutional holders
Comparable stocks
Frequently asked questions about AngioDynamics stock
What does AngioDynamics do?
AngioDynamics, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is James C. Clemmer, the company employs around 632 people.
The IPO was on 01/06/2004; the stock trades on NASDAQ under the ticker ANGO.
What do analysts say about AngioDynamics stock?
11 analysts rate the stock, the consensus is Hold (as of 13/10/2026).
The average price target is US$19.00, ranging from US$18.00 to US$20.00, with a median of US$19.00.
This is an external assessment, not a statement by Market Jury.
When does AngioDynamics report next?
The next earnings date is 06/01/2027.
Around past earnings, price swings were roughly 170% stronger than usual.
Does AngioDynamics pay a dividend?
No, AngioDynamics currently does not pay a dividend.
Which stocks are comparable to AngioDynamics?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get AngioDynamics stock analyzed?
Clicking "Analyze stock" lets five strategies assess AngioDynamics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.